Newsfeeds Archive - Spark Newswire

1 minute read

Bausch + Lomb Presents New Scientific Data And Evaluations Featuring Consumer, Vision Care And Pharmaceutical Products At Optometry’s Meeting June 19-22, 2024

May 28, 9:04 AM

15 ePosters and In-Person Presentations Will Include Clinical Data on Blink™ NutriTears® Supplement for Dry Eyes, Blink® Triple Care Lubricating Eye Drops and MIEBO® (Perfluorohexyloctane Ophthalmic

BLCO

2 minute read

American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday

By Avi Kapoor

May 6, 7:56 AM

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

AAL

4 minute read

Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed’s Powell For Relief: Why This Analyst Sees Incoming Summer Rally

By Shanthi Rexaline

May 1, 6:44 AM

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)

ALB

3 minute read

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

By Shanthi Rexaline

April 29, 1:51 AM

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

AAL

3 minute read

Bausch + Lomb Announces Results From A Clinical Study Of A Novel Daily Nutritional Supplement For Dry Eyes, All Primary Endpoints Achieved

By Benzinga Newsdesk

April 25, 8:43 AM

Novel Supplement Shown to Address Signs and Symptoms of Dry Eyes, All Primary Endpoints AchievedBausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live

BLCO

1 minute read

Earnings

Bausch & Lomb Earnings Preview

By Benzinga Insights

February 20, 11:01 AM

Bausch & Lomb (NYSE:BLCO) is set to give its latest quarterly earnings report on Wednesday, 2024-02-21. Here’s what…

BLCO

2 minute read

Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month

By Vandana Singh

February 9, 3:24 PM

"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins for 2024.

ALC